Where can I buy ANAVEX life sciences (avxl) stock?
Shares of AVXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Anavex Life Sciences' stock price today?
Where can I buy avxl shares?
Shares of AVXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What does avxlu stand for?
AVXLU.S.: Nasdaq Anavex Life Sciences Corp. WatchlistCreateAVXLAlert AVXLUS After Hours Last Updated: Jan 25, 2022 7:48 p.m. ESTDelayed quote
Why did ANAVEX stock jump 42%?
Anavex stock jumps 42% after company announces Biogen drug testing agreement Sep. 28, 2016 at 9:44 a.m. ETby Emma Court Anavex's stock surges after Alzheimer's treatment granted orphan drug designation Apr. 8, 2016 at 7:19 a.m. ETby Tomi Kilgore
Anavex Life Sciences (AVXL) Q1 2022 Earnings Call Transcript
With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer. Thank you, Clint, and we appreciate everyone joining us on today's conference call to review our most recently reported financial results, and to provide a business update.
Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.
Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 First Quarter Financial Results
Company to host a webcast today at 4:30 p.m. Eastern Time NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.
About Anavex Life Sciences
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases.
Anavex Life Sciences (NASDAQ:AVXL) Frequently Asked Questions
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anavex Life Sciences in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Anavex Life Sciences stock. View analyst ratings for Anavex Life Sciences or view top-rated stocks.
